Alcohol withdrawal syndrome
Showing 1 - 25 of >10,000
Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or
Completed
- Alcohol Withdrawal Syndrome
- BZDP-Sparing Protocol
- BZDP-Based Protocol
-
Stanford, CaliforniaStanford Hospital and Clinics
Jun 24, 2022
Alcohol Withdrawal Syndrome Trial in Rochester (Gabapentin, Benzodiazepines, Divalproex Sodium)
Completed
- Alcohol Withdrawal Syndrome
- Gabapentin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 1, 2022
Alcohol Withdrawal Trial in Copenhagen (Blood samples)
Recruiting
- Alcohol Withdrawal
- Blood samples
-
Copenhagen, DenmarkBispebjerg and Frederiksberg Hospital
Sep 28, 2022
Alcohol Withdrawal Syndrome Trial in France (Magnesium, Placebo Oral Tablet)
Completed
- Alcohol Withdrawal Syndrome
- Magnesium
- Placebo Oral Tablet
-
Colombes, Ile-de-France, France
- +10 more
Dec 20, 2021
Portrayal of Hospital Alcohol Detoxification in France
Completed
- Alcohol Use Disorder
- +2 more
- Stay for alcohol detoxification
-
Montpellier, FranceUhmontpellier
Oct 18, 2021
Alcohol Withdrawal Trial in New Haven (Prazosin, 12-Step Facilitation with Relapse Prevention and Contingency Management)
Recruiting
- Alcohol Withdrawal
- Prazosin
- 12-Step Facilitation with Relapse Prevention and Contingency Management
-
New Haven, Connecticut
- +1 more
Jan 13, 2022
Alcohol Withdrawal Delirium, Alcohol Withdrawal, Alcohol Withdrawal Seizures Trial (Phenobarbital Sodium, Inactive )
Unknown status
- Alcohol Withdrawal Delirium
- +2 more
- Phenobarbital Sodium
- Inactive placebo
- (no location specified)
Oct 5, 2020
Abuse and Addiction in ICU
Active, not recruiting
- Substance Withdrawal Syndrome
- AUDIT-C
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 18, 2021
Substance Use Disorders, Opiate Dependence, Opiate Withdrawal Syndrome Trial in McKeesport (Six Step Model of Self-Forgiveness,
Completed
- Substance Use Disorders
- +15 more
- Six Step Model of Self-Forgiveness
- Treatment as Usual (TAU)
-
McKeesport, PennsylvaniaUPMC McKeesport
Sep 3, 2021
Alcohol Use Disorder Trial in Baltimore (Mifepristone, Placebo - Cap)
Recruiting
- Alcohol Use Disorder
- Mifepristone
- Placebo - Cap
-
Baltimore, MarylandIntegrated Program for Substance Abuse Research
Jan 5, 2023
E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)
Not yet recruiting
- E-cigarette Use
- Withdrawal
- Transdermal Nicotine Patch
- Placebo Nicotine Patch
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Sep 28, 2023
Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome
Recruiting
- Cushing Syndrome
- MUSE biofeedback
-
Rochester, MinnesotaMayo Clinic
Oct 31, 2022
Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,
Recruiting
- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome
- microRNA-146a level
- +2 more
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jun 30, 2023
Alcohol Withdrawal, Psychophysiologic Reaction Trial in Vienna (auriStim, for auricular vagal stimulation)
Completed
- Alcohol Withdrawal
- Psychophysiologic Reaction
- auriStim, for auricular vagal stimulation
-
Vienna, AustriaMedical University of Vienna, Department of Psychiatry and Psych
Nov 10, 2021
Alcohol Withdrawal Trial in Toronto (Diazepam)
Recruiting
- Alcohol Withdrawal
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Apr 4, 2022
Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)
Not yet recruiting
- Opiate Withdrawal Syndrome
- Opioid Use
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Treatment Research Center
Aug 18, 2023
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Study of Exploratory Plasmatic Markers of Alcohol Withdrawal
Not yet recruiting
- Alcohol Withdrawal
-
Paris, FranceGHU APHP Nord - Université de Paris, Site Lariboisière Fernand-W
Jan 27, 2022
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Alcohol Withdrawal, Alcohol Use Disorder Trial in Manhasset (Transcutaneous Nerve Stimulation, Sham Stimulation)
Not yet recruiting
- Alcohol Withdrawal
- Alcohol Use Disorder
- Transcutaneous Nerve Stimulation
- Sham Stimulation
-
Manhasset, New YorkFeinstein Institutes for Medical Research, Northwell Health
Jan 25, 2022
Methadone vs. Transdermal Fentanyl for Opioid Withdrawal
Not yet recruiting
- Delirium in the Intensive Care Unit
- Administration of methadone instead of fentanyl patch
-
Kfar Saba, IsraelMeir medical center Kfar Saba
Jan 15, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Using Clonidine and/or Buprenorphine
Recruiting
- Withdrawal Syndrome
- Clonidine, Buprenorphine
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
May 28, 2023
Neonatal Abstinence Syndrome Trial in Charleston (Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System)
Completed
- Neonatal Abstinence Syndrome
- Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
-
Charleston, South CarolinaMedical University of South Carolina
Dec 7, 2022